ropinirole
ropinirole is listed in the FDA National Drug Code directory with 39 NDC codes, marketed under brand names including ropinirole, Ropinirole, ROPINIROLE. Available dosage forms: tablet, film coated, tablet, extended release.
Drug Details
- Generic Name
- ropinirole
- Brand Names
- ropinirole, Ropinirole, ROPINIROLE
- Application Number
- ANDA204022
- Sponsor
- A-S Medication Solutions
- NDC Codes
- 39
- Dosage Forms
- TABLET, FILM COATED, TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Active Ingredients
- ROPINIROLE HYDROCHLORIDE, ROPINIROLE
Indications and Usage
1 INDICATIONS AND USAGE Ropinirole tablets are a non-ergoline dopamine agonist indicated for the treatment of Parkinson’s disease (PD) and moderate-to-severe primary Restless Legs Syndrome (RLS). ( 1.1 , 1.2 ) 1.1 Parkinson’s Disease Ropinirole tablets are indicated for the treatment of Parkinson's disease. 1.2 Restless Legs Syndrome Ropinirole tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).